KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Resmed (RMD) Enterprise Value (2016 - 2025)

Historic Enterprise Value for Resmed (RMD) over the last 17 years, with Q4 2025 value amounting to -$1.4 billion.

  • Resmed's Enterprise Value fell 17149.83% to -$1.4 billion in Q4 2025 from the same period last year, while for Dec 2025 it was -$1.4 billion, marking a year-over-year decrease of 17149.83%. This contributed to the annual value of -$1.2 billion for FY2025, which is 40740.26% down from last year.
  • Per Resmed's latest filing, its Enterprise Value stood at -$1.4 billion for Q4 2025, which was down 17149.83% from -$1.4 billion recorded in Q3 2025.
  • In the past 5 years, Resmed's Enterprise Value registered a high of -$194.5 million during Q4 2021, and its lowest value of -$1.4 billion during Q4 2025.
  • Over the past 5 years, Resmed's median Enterprise Value value was -$245.8 million (recorded in 2022), while the average stood at -$458.8 million.
  • Its Enterprise Value has fluctuated over the past 5 years, first skyrocketed by 3624.65% in 2021, then plummeted by 40740.26% in 2025.
  • Quarter analysis of 5 years shows Resmed's Enterprise Value stood at -$194.5 million in 2021, then crashed by 30.2% to -$253.2 million in 2022, then increased by 16.96% to -$210.2 million in 2023, then plummeted by 148.25% to -$521.9 million in 2024, then plummeted by 171.5% to -$1.4 billion in 2025.
  • Its last three reported values are -$1.4 billion in Q4 2025, -$1.4 billion for Q3 2025, and -$1.2 billion during Q2 2025.